EUVIMEDScopri EUVIMED
Systematische ÜbersichtMetaanalyseOpen access

Effectiveness of Mobile Health–Based Self-Management Programs on Health-Related Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis

Wirksamkeit mobiler gesundheitsbasierter Selbstmanagementprogramme auf gesundheitsbezogene Outcomes bei Patient:innen mit chronisch obstruktiver Lungenerkrankung: systematische Übersichtsarbeit und Metaanalyse

Galuh Nawang Prawesti iD, Pinyi Lo iD, Made Ary Sarasmita iD, Hsiang Yin Chen iD

JMIR mHealth and uHealth · 2025-12-29 · 13 · e74967-e74967

DOI: 10.2196/74967 ↗

Auf einen Blick

Bei 36 RCTs mit 5606 Patient:innen verbesserten mHealth-Selbstmanagementprogramme Dyspnoe und 6MWT bei COPD. Für den SGRQ-Score zeigte sich kein statistisch signifikanter Effekt.

Fragestellung

Wie wirksam sind mHealth-basierte Selbstmanagementprogramme bei COPD im Vergleich zu nicht-mHealth-Interventionen?

Methode

Systematische Übersichtsarbeit und Metaanalyse von RCTs; Suche in PubMed, Embase, CINAHL, Web of Science, Cochrane und Scopus für Januar 2015 bis September 2024; RoB 2.

Ergebnisse

mMRC: mittlere Differenz −0,65 (95 %-KI −1,14 bis −0,16; P =.02). 6MWT: 25,96 m (95 %-KI 10,05 bis 41,87; P =.004). SGRQ: −3,56 (95 %-KI −7,39 bis 0,27; P =.07).

Schlussfolgerung der Autor:innen

Die Übersichtsarbeit unterstützt die GOLD-2025-Empfehlungen und sieht mHealth als ergänzendes klinisches Instrument; weitere große Studien sind nötig.

Kernaussagen

  • mMRC-Dyspnoe und 6MWT verbesserten sich unter mHealth
  • Kein statistisch signifikanter Effekt auf den SGRQ-Gesamtscore
  • Ökonomische und klinische Ergebnisse waren teils günstig, teils uneinheitlich

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in JMIR mHealth and uHealth, published online on 2025-12-29. Written by Galuh Nawang Prawesti and 3 co-authors. Institution: Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, No.301, Yuantong Road, Zhonghe District, Taipei,…. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Self-Management, Outcome Assessment, Health Care. Cited 3 times so far (Crossref); 104 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The progression of chronic obstructive pulmonary disease (COPD) leads to increased morbidity and mortality, emphasizing the need for effective self-management. Challenges such as accessibility, cost, and patient engagement hinder self-management efforts, underscoring the need for evidence-based mobile health (mHealth) interventions.

Objective

This meta-analysis evaluated randomized controlled trials (RCTs) on the effectiveness of mHealth self-management programs for COPD, focusing on the modified Medical Research Council (mMRC) dyspnea scale, the 6-minute walking test (6MWT), and the St. George’s Respiratory Questionnaire (SGRQ) score. The secondary outcomes include quality-adjusted life years and costs as economic outcomes; exacerbation, hospitalization, and emergency room and clinic visits as clinical outcomes; and self-efficacy as a humanistic outcome.

Methods

The inclusion criteria encompassed RCTs involving patients with COPD aged 18 years and older, comparing mHealth-based self-management programs to non-mHealth interventions, with outcomes measured using the mMRC dyspnea scale, 6MWT, and SGRQ score. Exclusion criteria included observational studies, reviews, qualitative research, protocols, and non-English publications. A comprehensive search was conducted across PubMed, Embase, CINAHL, Web of Science, Cochrane, and Scopus using predefined keywords and MeSH terms for studies published between January 2015 and September 2024. The risk of bias was assessed using the Cochrane Risk-of-Bias 2 tool. Data extraction encompassed study characteristics, interventions, comparators, and outcomes. Meta-analyses were performed for outcomes reported in at least 3 RCTs using R software (version 4.2.2; R Foundation for Statistical Computing).

Results

This systematic review included 36 RCTs from diverse geographical regions, encompassing 5606 patients. The meta-analysis revealed significant improvements in the mMRC dyspnea scale (mean difference −0.65, 95% CI −1.14 to −0.16; P =.02) and 6MWT (mean difference 25.96 m, 95% CI 10.05 m to 41.87 m; P =.004) in the mHealth intervention group compared to controls. However, no statistical significance was observed in the SGRQ total score (mean difference −3.56, 95% CI −7.39 to 0.27; P =.07). A total of 2 studies reported economic results, with a possible statistically significant decrease in the mean cost per patient (€3547 vs €4831 [US $4118.4 vs US $5609.24]; P =.01), but no statistically significant difference in quality-adjusted life years (0.485 vs 0.491; P =.73). A total of 5 studies reported substantial reductions in hospital admissions. Additionally, 1 study each reported significant improvements in time to first readmission for COPD exacerbations, clinic visits, mortality rates, and exacerbation frequencies. A single study reported a significant improvement in self-efficacy, as measured by the Pulmonary Rehabilitation Adapted Index of Self-Efficacy scores.

Conclusions

This review supports the Global Initiative for Chronic Obstructive Lung Disease 2025 recommendations, highlighting mHealth as a supplementary clinical tool requiring patient education, ethical compliance, and informed consent. Further large-scale studies are needed to refine mHealth tools, ensuring accessibility, long-term safety, and effectiveness across diverse populations and outcome domains.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveSelf-ManagementOutcome Assessment, Health CareHumansTelemedicineRandomized Controlled Trials as TopicSurveys and Questionnaires

Author keywords

COPDchronic diseasechronic obstructive pulmonary diseasedyspneamHealthmobile healthself-management

Authors and institutions

  • Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, No.301, Yuantong Road, Zhonghe District, Taipei, 235, Taiwan, 886 2-2736-1661 ext 6175.
  • Department of Clinical and Community Pharmacy, Faculty of Pharmacy, Widya Mandala Surabaya Catholic University, Surabaya, Indonesia.
  • Department of Pharmacy, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
  • Program Study of Pharmacy, Faculty of Mathematics and Science, Udayana University, Badung, Indonesia.
  • Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

ORCID profiles: Galuh Nawang Prawesti, Pinyi Lo, Made Ary Sarasmita, Hsiang Yin Chen

Cite

APA

Prawesti, G. N., Lo, P., Sarasmita, M. A., & Chen, H. Y. (2025). Effectiveness of Mobile Health–Based Self-Management Programs on Health-Related Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. JMIR mHealth and uHealth, 13, e74967-e74967. https://doi.org/10.2196/74967

Vancouver

Prawesti GN, Lo P, Sarasmita MA, Chen HY. Effectiveness of Mobile Health–Based Self-Management Programs on Health-Related Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. JMIR mHealth and uHealth. 2025;13:e74967-e74967. doi:10.2196/74967

BibTeX
@article{Prawesti2025,
  author = {Prawesti, Galuh Nawang and Lo, Pinyi and Sarasmita, Made Ary and Chen, Hsiang Yin},
  title = {Effectiveness of Mobile Health–Based Self-Management Programs on Health-Related Outcomes in Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis},
  journal = {JMIR mHealth and uHealth},
  year = {2025},
  volume = {13},
  pages = {e74967--e74967},
  doi = {10.2196/74967}
}
Start for free →